Image

Open-Label Proof of Concept Study of VP-315 in Basal Cell Carcinoma

Study exploring VP-315 for treating basal cell carcinoma.

Recruiting
18 years and older
All
Phase 2

Basal Cell Carcinoma (BCC) is a common type of skin cancer. This study is testing a new treatment called VP-315, which is injected directly into the cancer spots on the skin. The study will involve about 80 adults with BCC, and it will take place at several locations. The goal is to find out how safe the treatment is and how well it works.

People in the study will get the treatment for 3 days each week, followed by 4 days with no treatment. The study will last for several weeks, and participants will need to visit the study site regularly to get the injections and have their progress checked.

  • The study involves multiple visits and regular injections.
  • Participants should avoid certain skin products and sunlight during the study.
  • Participants must be willing to have surgery on the BCC spots after the study ends.

Before joining, participants must meet specific criteria, such as being 18 years or older and having BCC spots that can be biopsied. Certain health conditions and treatments may exclude someone from participating. Participants will need to use effective birth control during the study and for 4 weeks after the last treatment. They must also agree to photographs of their skin being taken for study purposes.

Study details
    Basal Cell Carcinoma
    Skin Cancer
    Cancer of the Skin
    Basal Cell
    Cancer of the Skin
    Carcinoma

NCT05188729

Verrica Pharmaceuticals Inc.

13 December 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.